Evidence map›Paper›PMID 18432756›Full record

ArticleCurrent protocols in immunology2001

Animal models of mycobacteria infection.

I M Orme, A D Roberts

Abstract read
In one paragraph

Article in Current protocols in immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

I M OrmeMycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA.
A D Roberts

Funding

Response Therapies for MDR-TBU01AI070456 · NIAID · COLORADO STATE UNIVERSITY · PI ORME, IAN M · 2006 to 2010
$6.4M
CHRONIC TUBERCULOSIS--LATENT OR DYNAMICR01AI044072 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI ORME, IAN M · 1999 to 2008
$2.7M
Immune modulation by highly virulent clinical isolates of M.tuberculosisDP2OD006450 · OD · COLORADO STATE UNIVERSITY · PI ORDWAY, DIANE JOYCE · 2009 to 2009
$2.0M
DEFINED NATIVE ANTIGENS AND IMMUNITY TO TUBERCULOSISR01AI040488 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI ORME, IAN M · 1996 to 2006
$1.6M
Induction of regulatory T cells by highly virulent isolates of M.tuberculosisR21AI081959 · NIAID · COLORADO STATE UNIVERSITY · PI ORDWAY, DIANE JOYCE · 2010 to 2011
$402k
NIAID NIH HHS R01 AI040488NIAID NIH HHS R01 AI044072NIAID NIH HHS R21 AI081959NIAID NIH HHS U01 AI070456NIH HHS DP2 OD006450
6 · The paper itself

Abstract

This unit describes the infection of mice and guinea pigs with mycobacteria via the aerogenic route, or of mice via the intravenous route, as well as necropsy methods for the determination of mycobacterial loads within target organs. Additionally, methods for cultivating mycobacteria and preparing stocks are described. The protocols outlined are primarily used for M. tuberculosis, but can also be used for the study of other opportunistic Mycobacterial species.

Indexed as

Disease Models, AnimalMycobacterium InfectionsMycobacterium tuberculosisAnimalsGuinea PigsMice

Identifiers

PMID18432756
PMCPMC3169425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.